These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35352632)

  • 1. Secondary Immunosuppression in Pediatric Kidney Transplant Recipients.
    Serrano Pejenaute I; Lejarzegi Anakabe E; Madariaga L; Alonso Varela M; Santos-Diez Vázquez L; Herrero Goñi M
    Exp Clin Transplant; 2022 Mar; 20(3):258-264. PubMed ID: 35352632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EBV, CMV, and BK viral infections in pediatric kidney transplantation: Frequency, risk factors, treatment, and outcomes.
    Levi S; Davidovits M; Alfandari H; Dagan A; Borovitz Y; Bilavsky E; Landau D; Haskin O
    Pediatr Transplant; 2022 May; 26(3):e14199. PubMed ID: 34817112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-lasting chronic high load carriage of Epstein-Barr virus is more common in young pediatric renal transplant recipients.
    Ladfors SW; Lindahl JK; Hansson S; Brandström P; Andersson R; Jertborn M; Lindh M; Woxenius S; Friman V
    Pediatr Nephrol; 2020 Mar; 35(3):427-439. PubMed ID: 31802220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective monitoring of cytomegalovirus, Epstein-Barr virus, BK virus, and JC virus infections on belatacept therapy after a kidney transplant.
    Bassil N; Rostaing L; Mengelle C; Kallab S; Esposito L; Guitard J; Cardeau-Desangles I; Weclawiak H; Izopet J; Kamar N
    Exp Clin Transplant; 2014 Jun; 12(3):212-9. PubMed ID: 24907721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.
    Schubert S; Renner C; Hammer M; Abdul-Khaliq H; Lehmkuhl HB; Berger F; Hetzer R; Reinke P
    J Heart Lung Transplant; 2008 Jan; 27(1):100-5. PubMed ID: 18187094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretransplant Epstein-Barr virus serostatus and incidence of posttransplant lymphoproliferative disorder in pediatric renal transplants.
    Rahimzadeh N; Otukesh H; Hoseini R; Riahifard A
    Exp Clin Transplant; 2013 Aug; 11(4):299-302. PubMed ID: 23905908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of viral DNA in kidney graft preservation and washing solutions is predictive of posttransplant infections in pediatric recipients.
    Barzon L; Murer L; Pacenti M; Biasolo MA; Vella MD; Ghirardo G; Gamba PG; De Arias AE; Zanon GF; Palù G
    J Infect Dis; 2009 Nov; 200(9):1425-33. PubMed ID: 19803803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Factors on Graft Function in Pediatric Kidney Recipients.
    Oomen L; de Wall LL; Cornelissen EAM; Feitz WFJ; Bootsma-Robroeks CMHHT
    Transplant Proc; 2021 Apr; 53(3):889-896. PubMed ID: 33257001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment strategies to minimize or prevent chronic allograft dysfunction in pediatric renal transplant recipients: an overview.
    Höcker B; Tönshoff B
    Paediatr Drugs; 2009; 11(6):381-96. PubMed ID: 19877724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors and long-term outcomes of pediatric liver transplant recipients with chronic high Epstein-Barr virus loads.
    Kamei H; Ito Y; Kawada J; Ogiso S; Onishi Y; Komagome M; Kurata N; Ogura Y
    Transpl Infect Dis; 2018 Aug; 20(4):e12911. PubMed ID: 29677384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of PCR results in the diagnosis of Epstein-Barr virus infections].
    Karadağ Geçgel S; Ersoy A; Sevinir BB; Sınırtaş M; Göral G
    Mikrobiyol Bul; 2012 Oct; 46(4):594-606. PubMed ID: 23188573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virus-specific T cells in pediatric renal transplantation.
    Ahlenstiel-Grunow T; Pape L
    Pediatr Nephrol; 2021 Apr; 36(4):789-796. PubMed ID: 32221706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of Belatacept on virus-specific memory versus de novo allo-specific T cell responses of kidney transplant recipients and healthy donors.
    Kühne JF; Neudörfl C; Beushausen K; Keil J; Malysheva S; Wandrer F; Haller H; Messerle M; Blume C; Neuenhahn M; Schlott F; Hammerschmidt W; Zeidler R; Falk CS
    Transpl Immunol; 2020 Aug; 61():101291. PubMed ID: 32330566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus load for early detection of lymphoproliferative disorder in pediatric renal transplant recipients.
    Ishihara M; Tanaka E; Sato T; Chikamoto H; Hisano M; Akioka Y; Dohno S; Maeda A; Hattori M; Wakiguchi H; Fujieda M
    Clin Nephrol; 2011 Jul; 76(1):40-8. PubMed ID: 21722604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring of Epstein-Barr virus load and killer T cells in pediatric renal transplant recipients.
    Sato T; Fujieda M; Maeda A; Tanaka E; Miyamura M; Chikamoto H; Hisano M; Akioka Y; Ishiura Y; Dohno S; Hattori M; Wakiguchi H
    Clin Nephrol; 2008 Nov; 70(5):393-403. PubMed ID: 19000539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience.
    Wasson S; Zafar MN; Best J; Reddy HK
    J Cardiovasc Pharmacol Ther; 2006 Mar; 11(1):77-83. PubMed ID: 16703222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A New Clinical and Immunovirological Score for Predicting the Risk of Late Severe Infection in Solid Organ Transplant Recipients: The CLIV Score.
    San-Juan R; Fernández-Ruiz M; Ruiz-Ruigómez M; López-Medrano F; Ruiz-Merlo T; Andrés A; Loinaz C; Len O; Azancot MA; Montejo M; Rodriguez-Alvarez R; Fortún J; Escudero-Sánchez R; Giménez E; Lora D; Albert E; Navarro D; Aguado JM;
    J Infect Dis; 2020 Jul; 222(3):479-487. PubMed ID: 32112085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary Epstein-Barr virus infection, seroconversion, and post-transplant lymphoproliferative disorder in seronegative renal allograft recipients: a prospective cohort study.
    Hosseini-Moghaddam SM; Alhomayeed B; Soliman N; Weir MA; House AA
    Transpl Infect Dis; 2016 Jun; 18(3):423-30. PubMed ID: 27016725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus DNAemia in Iranian liver transplant recipients and assessment of its variation in posttransplant lymphproliferative disorder patients by quantitative polymerase chain reaction assay.
    Jamalidoust M; Geramizadeh B; Pouladfar G; Namayandeh M; Asaie S; Aliabadi N; Nikeghbalian S; Ziyaeyan M
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():306-11. PubMed ID: 25894179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymptomatic high Epstein-Barr viral load carriage in pediatric renal transplant recipients.
    Tanaka E; Sato T; Ishihara M; Tsutsumi Y; Hisano M; Chikamoto H; Akioka Y; Dohno S; Maeda A; Hattori M; Wakiguchi H; Fujieda M
    Pediatr Transplant; 2011 May; 15(3):306-13. PubMed ID: 21492352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.